InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Wierenga Wendall. Director active across 3 companies, notably Cytokinetics INC. In total, 34 filings have been recorded. History available since 12 May 2021. The latest transaction was disclosed on 15 July 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Wierenga Wendall
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations34 total
164 shares@ US$38.01100.0% of flowCommon StockSEC:0001127602-25-019290:0
6,900 shares0Common StockSEC:0000950170-25-086260:0
7,333 shares0Common StockSEC:0001127602-25-014355:0
20,000 shares@ US$6.2124.0% of flowCommon StockSEC:0001127602-25-012398:0
162 shares@ US$38.561.2% of flowCommon StockSEC:0001127602-25-012113:0
127 shares@ US$48.931.3% of flowCommon StockSEC:0001127602-25-000758:0
742 shares@ US$7.371.2% of flowCommon StockSEC:0001127602-24-029523:0
742 shares@ US$7.371.2% of flowCommon StockSEC:0001127602-24-028124:0
4,452 shares@ US$7.376.8% of flowCommon StockSEC:0001127602-24-026161:0
118 shares@ US$52.601.2% of flowCommon StockSEC:0001127602-24-025194:0
114 shares0Common StockSEC:0001127602-24-020149:0
3,400 shares0Common StockSEC:0000950170-24-071921:0
5,600 shares0Common StockSEC:0001127602-24-015719:0
74 shares@ US$84.121.3% of flowCommon StockSEC:0001127602-24-000433:0
5,000 shares@ US$4.444.5% of flowCommon StockSEC:0001127602-23-030485:0
448 shares@ US$27.882.7% of flowCommon StockSEC:0001127602-23-025166:0
6,020 shares@ US$6.728.3% of flowCommon StockSEC:0001127602-23-023012:0
374 shares@ US$33.362.5% of flowCommon StockSEC:0001127602-23-020064:0
6,000 shares0Common StockSEC:0001209191-23-038827:0
5,000 shares0Common StockSEC:0001127602-23-016196:0
298 shares@ US$37.712.3% of flowCommon StockSEC:0001127602-23-012541:0
7,000 shares@ US$6.729.7% of flowCommon StockSEC:0001127602-23-003984:0
253 shares@ US$44.352.3% of flowCommon StockSEC:0001127602-23-000714:0
110 shares@ US$51.111.3% of flowCommon StockSEC:0001127602-22-023701:0
4,166 shares@ US$6.786.3% of flowCommon StockSEC:0001127602-22-021922:0
25 of 34 declarations
About Wierenga Wendall
WIERENGA WENDALL is a Director at CYTOKINETICS INC, Crinetics Pharmaceuticals, Inc., and Cytokinetics INC. He has 34 filings in total, and the sampled filings cover the period from 2021-05-13 to 2025-07-16. The largest amounts in these filings are attribution entries, including 107880.1217567188 EUR on 2025-04-21 at CYTOKINETICS INC.
